PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA. Electronic address: jlaurenc@med.cornell.edu.\', \'Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.\', \'Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Medicine, Division of Cardiology, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(20)30665-310.1016/j.clim.2020.108555
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 32771488
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32771488>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32771488>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all